Literature DB >> 35141065

Acute Urticaria as the First Symptom of COVID-19: A Case Report.

Diego M Watashi1, Diogo R Sene2, Júlia B Garófalo1, Renan H Merlini3, Alexandre B Merlini4.   

Abstract

During the SARS-CoV-2 pandemic, various rashes associated with COVID-19 infection have been reported, including urticaria. Urticaria is a limited and usually benign condition, presenting as pruritic wheals, with or without edema. A 39-year-old woman presented with a pruritic rash on her arms spreading to her trunk and face over two days, followed by headache, nausea, vomiting, abdominal discomfort, diarrhea, myalgia, arthralgia, anosmia, and dyspepsia for three days. Fever, dry cough, and odynophagia started on the day of the consult. The patient had a history of hypertension but denied a history of atopic conditions, similar previous presentations, or recent ingestion of new medications. SARS-CoV-2 COVID-19 PCR testing was positive. She was prescribed oral antihistamine for the itching and was discharged. During a follow-up after two weeks, the patient was asymptomatic with complete resolution of the rash on day 7 of symptoms. Knowing the cutaneous manifestations of COVID-19 can aid in the early identification of this disease and prevent misdiagnosis. The presence of cutaneous manifestations in COVID-19 is suggested to be related to disease severity, but data are needed to study any prognostic value of dermatologic manifestations in COVID-19.
Copyright © 2021, Watashi et al.

Entities:  

Keywords:  case report; covid-19; cutaneous manifestations; sars-cov-2; skin lesions; urticaria

Year:  2021        PMID: 35141065      PMCID: PMC8802665          DOI: 10.7759/cureus.20806

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  6 in total

1.  Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.

Authors:  Jin-Jin Zhang; Xiang Dong; Yi-Yuan Cao; Ya-Dong Yuan; Yi-Bin Yang; You-Qin Yan; Cezmi A Akdis; Ya-Dong Gao
Journal:  Allergy       Date:  2020-02-27       Impact factor: 13.146

Review 2.  Acute and Chronic Urticaria: Evaluation and Treatment.

Authors:  Paul Schaefer
Journal:  Am Fam Physician       Date:  2017-06-01       Impact factor: 3.292

Review 3.  Cutaneous manifestations of COVID-19: Report of three cases and a review of literature.

Authors:  Muskaan Sachdeva; Raffaele Gianotti; Monica Shah; Lucia Bradanini; Diego Tosi; Stefano Veraldi; Michael Ziv; Eyal Leshem; Roni P Dodiuk-Gad
Journal:  J Dermatol Sci       Date:  2020-04-29       Impact factor: 4.563

4.  COVID-19 and dermatology.

Authors:  Ülker Gül
Journal:  Turk J Med Sci       Date:  2020-06-30       Impact factor: 0.973

5.  Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases.

Authors:  C Galván Casas; A Català; G Carretero Hernández; P Rodríguez-Jiménez; D Fernández-Nieto; A Rodríguez-Villa Lario; I Navarro Fernández; R Ruiz-Villaverde; D Falkenhain-López; M Llamas Velasco; J García-Gavín; O Baniandrés; C González-Cruz; V Morillas-Lahuerta; X Cubiró; I Figueras Nart; G Selda-Enriquez; J Romaní; X Fustà-Novell; A Melian-Olivera; M Roncero Riesco; P Burgos-Blasco; J Sola Ortigosa; M Feito Rodriguez; I García-Doval
Journal:  Br J Dermatol       Date:  2020-06-10       Impact factor: 11.113

6.  Management of urticaria in COVID-19 patients: A systematic review.

Authors:  Eyad Abuelgasim; Ann Christine Modaragamage Dona; Rajan Singh Sondh; Amer Harky
Journal:  Dermatol Ther       Date:  2020-10-09       Impact factor: 3.858

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.